Kuros Biosciences AG (KURN) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.031x

Based on the latest financial reports, Kuros Biosciences AG (KURN) has a cash flow conversion efficiency ratio of -0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-2.24 Million ≈ $-2.83 Million USD) by net assets (CHF72.00 Million ≈ $91.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KURN market cap for the company's overall valuation and market capitalisation.

Kuros Biosciences AG - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Kuros Biosciences AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kuros Biosciences AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kuros Biosciences AG ranked by their cash flow conversion efficiency. Explore KURN cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Riley Exploration Permian Inc
NYSE MKT:REPX
0.085x
Tianjin Economic-technological Development Area Co Ltd
SHE:000652
0.044x
Shanghai Orient-Chip Technology Co. Ltd. A
SHG:688061
N/A
Recticel
BR:RECT
0.083x
Amtran Technology Co Ltd
TW:2489
-0.032x
Decai Decoration Co Ltd
SHG:605287
0.009x
Ceigall India
NSE:CEIGALL
-0.081x
Nuh Cimento Sanayi AS
IS:NUHCM
0.028x

Annual Cash Flow Conversion Efficiency for Kuros Biosciences AG (2004–2025)

The table below shows the annual cash flow conversion efficiency of Kuros Biosciences AG from 2004 to 2025. View KURN stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF66.93 Million
≈ $84.62 Million
CHF-377.87K
≈ $-477.73K
-0.006x -110.56%
2024-12-31 CHF58.75 Million
≈ $74.27 Million
CHF3.14 Million
≈ $3.97 Million
0.053x +134.27%
2023-12-31 CHF56.71 Million
≈ $71.70 Million
CHF-8.84 Million
≈ $-11.18 Million
-0.156x -46.14%
2022-12-31 CHF68.86 Million
≈ $87.06 Million
CHF-7.35 Million
≈ $-9.29 Million
-0.107x -50.63%
2021-12-31 CHF76.98 Million
≈ $97.32 Million
CHF-5.45 Million
≈ $-6.89 Million
-0.071x +35.13%
2020-12-31 CHF84.60 Million
≈ $106.96 Million
CHF-9.24 Million
≈ $-11.68 Million
-0.109x +21.63%
2019-12-31 CHF77.86 Million
≈ $98.43 Million
CHF-10.85 Million
≈ $-13.72 Million
-0.139x +16.98%
2018-12-31 CHF76.48 Million
≈ $96.70 Million
CHF-12.84 Million
≈ $-16.23 Million
-0.168x -14.97%
2017-12-31 CHF73.14 Million
≈ $92.47 Million
CHF-10.68 Million
≈ $-13.50 Million
-0.146x +37.09%
2016-12-31 CHF38.32 Million
≈ $48.45 Million
CHF-8.89 Million
≈ $-11.24 Million
-0.232x +93.82%
2015-12-31 CHF669.00K
≈ $845.80K
CHF-2.51 Million
≈ $-3.18 Million
-3.758x -514.73%
2014-12-31 CHF-26.22 Million
≈ $-33.15 Million
CHF-23.76 Million
≈ $-30.04 Million
0.906x +119.99%
2013-12-31 CHF4.23 Million
≈ $5.35 Million
CHF-19.17 Million
≈ $-24.24 Million
-4.532x -293.95%
2012-12-31 CHF10.03 Million
≈ $12.68 Million
CHF-11.54 Million
≈ $-14.59 Million
-1.150x -252.56%
2011-12-31 CHF-11.68 Million
≈ $-14.77 Million
CHF-8.81 Million
≈ $-11.13 Million
0.754x +206.14%
2010-12-31 CHF6.59 Million
≈ $8.34 Million
CHF-4.68 Million
≈ $-5.92 Million
-0.710x +61.61%
2009-12-31 CHF8.24 Million
≈ $10.42 Million
CHF-15.25 Million
≈ $-19.28 Million
-1.850x -111.33%
2008-12-31 CHF31.86 Million
≈ $40.28 Million
CHF-27.89 Million
≈ $-35.27 Million
-0.876x -983.67%
2007-12-31 CHF54.43 Million
≈ $68.82 Million
CHF-4.40 Million
≈ $-5.56 Million
-0.081x +87.07%
2006-12-31 CHF45.90 Million
≈ $58.03 Million
CHF-28.67 Million
≈ $-36.25 Million
-0.625x -70.75%
2005-12-31 CHF74.01 Million
≈ $93.57 Million
CHF-27.08 Million
≈ $-34.23 Million
-0.366x -29.32%
2004-12-31 CHF80.17 Million
≈ $101.36 Million
CHF-22.68 Million
≈ $-28.68 Million
-0.283x --

About Kuros Biosciences AG

SW:KURN Switzerland Medical Devices
Market Cap
$846.66 Million
CHF669.68 Million CHF
Market Cap Rank
#10404 Global
#129 in Switzerland
Share Price
CHF16.88
Change (1 day)
-5.38%
52-Week Range
CHF16.88 - CHF33.36
All Time High
CHF36.96
About

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; Ma… Read more